Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease
- 1 July 2022
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 20 (7) , 1579-1587.e2
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Nippon Kayaku
- Novartis
- AbbVie Canada
- Roche
- Seres Therapeutics (4SC)
- Yale University
- Diagnostic Services Manitoba
- Eli Lilly and Company
- Takeda Canada
- Schering-Plough
- Boehringer Ingelheim
- Janssen Pharmaceutica
- Abbott Laboratories
- Shire
- Gilead Sciences
- MedImmune
- Teva Pharmaceutical Industries
- Ferring Pharmaceuticals
This publication has 28 references indexed in Scilit:
- Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled TrialsClinical Gastroenterology and Hepatology, 2015
- Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2015
- Comparative Efficacy of Biologic Therapy in Biologic-Naïve Patients With Crohn Disease: A Systematic Review and Network Meta-analysisMayo Clinic Proceedings, 2014
- Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment FailedGastroenterology, 2014
- Comparative Effectiveness of Infliximab and Adalimumab for Crohn's DiseaseClinical Gastroenterology and Hepatology, 2014
- Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONICGastroenterology, 2013
- Vedolizumab as Induction and Maintenance Therapy for Crohn's DiseaseNew England Journal of Medicine, 2013
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Antibody Pharmacokinetics and PharmacodynamicsJournal of Pharmaceutical Sciences, 2004